Our fact sheet offers a deeper look at this topic.
Nuclear innovation can close the scarcity gap
The TerraPower Isotopes® (TPI™) program supports medical research and innovation by developing advanced radioisotope generators that enable efficient and automatic extraction of rare isotopes that have potentially life-saving qualities.
Learn more about medical isotopes
Select isotopic materials may be effectively used in Targeted Alpha Therapy for cancer patients.
TerraPower’s assessment shows that select isotopic materials harvested from material stored by the U.S. Department of Energy (DOE) may be effectively used in Targeted Alpha Therapy for cancer patients. Researchers believe that these alpha-emitting isotopes may help to destroy targeted cancer cells with minimum damage to healthy cells.
TerraPower’s radiochemistry laboratory also supports other radioisotope development initiatives within the company as part of its nuclear innovation mission.Download Medical Isotopes Infographic